| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | somatodendritic compartment | MAPT PALMD PTK2 ADD1 NRP1 SLIT2 DIP2A GLRB DHODH AGFG1 AFDN LRRC7 DIP2B FLNB STRN3 MYOT CLIP2 PCLO ITGA8 GRM8 PPP1CC AKAP9 CPEB4 LRP4 UBXN2A HDC KIF1C | 4.66e-05 | 1228 | 200 | 27 | GO:0036477 |
| GeneOntologyCellularComponent | cell-substrate junction | SYNPO2 ITGA2 ERBIN PTK2 ADD1 ABCB4 NRP1 AHNAK FLNB ITGA8 PPP1CC HMCN1 SSH2 RPL8 | 9.89e-05 | 443 | 200 | 14 | GO:0030055 |
| GeneOntologyCellularComponent | immunoglobulin complex | IGHV5-10-1 IGHV5-51 IGHV1-69-2 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3 IGHV7-4-1 | 2.03e-04 | 166 | 200 | 8 | GO:0019814 |
| GeneOntologyCellularComponent | dendrite | MAPT PALMD PTK2 ADD1 SLIT2 DIP2A GLRB LRRC7 DIP2B STRN3 CLIP2 PCLO ITGA8 PPP1CC AKAP9 CPEB4 LRP4 UBXN2A HDC KIF1C | 2.25e-04 | 858 | 200 | 20 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | MAPT PALMD PTK2 ADD1 SLIT2 DIP2A GLRB LRRC7 DIP2B STRN3 CLIP2 PCLO ITGA8 PPP1CC AKAP9 CPEB4 LRP4 UBXN2A HDC KIF1C | 2.32e-04 | 860 | 200 | 20 | GO:0097447 |
| GeneOntologyCellularComponent | postsynapse | GAPDH MAPT RTN3 PALMD ERBIN PTK2 ADD1 NRP1 DIP2A GLRB AFDN LRRC7 STRN3 ANK1 PCLO ITGA8 PPP1CC AKAP9 CPEB4 LRP4 SLC29A1 RPL8 | 3.13e-04 | 1018 | 200 | 22 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic specialization | GAPDH MAPT RTN3 ERBIN ADD1 GLRB AFDN LRRC7 PCLO ITGA8 AKAP9 CPEB4 LRP4 RPL8 | 3.64e-04 | 503 | 200 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | dendritic spine | 5.58e-04 | 242 | 200 | 9 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 6.46e-04 | 247 | 200 | 9 | GO:0044309 | |
| GeneOntologyCellularComponent | focal adhesion | SYNPO2 ITGA2 PTK2 ADD1 ABCB4 NRP1 AHNAK FLNB ITGA8 PPP1CC SSH2 RPL8 | 9.51e-04 | 431 | 200 | 12 | GO:0005925 |
| GeneOntologyCellularComponent | anchoring junction | SYNPO2 CDHR3 ITGA2 ERBIN PTK2 ADD1 ABCB1 ABCB4 NRP1 AHNAK AFDN LRRC7 FLNB EPB41L4B ITGA8 PPP1CC HMCN1 SSH2 PATJ RPL8 | 1.14e-03 | 976 | 200 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | costamere | 1.16e-03 | 22 | 200 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | myofibril | 1.31e-03 | 273 | 200 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | host intracellular region | 1.33e-03 | 6 | 200 | 2 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 1.33e-03 | 6 | 200 | 2 | GO:0030430 | |
| GeneOntologyCellularComponent | host cell part | 1.33e-03 | 6 | 200 | 2 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 1.33e-03 | 6 | 200 | 2 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 1.33e-03 | 6 | 200 | 2 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 1.33e-03 | 6 | 200 | 2 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 1.33e-03 | 6 | 200 | 2 | GO:0020005 | |
| GeneOntologyCellularComponent | postsynaptic density | GAPDH MAPT RTN3 ADD1 AFDN LRRC7 PCLO ITGA8 AKAP9 CPEB4 LRP4 RPL8 | 1.40e-03 | 451 | 200 | 12 | GO:0014069 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | NCOA3 GBP7 GAPDH BAG1 GBP2 ITGA2 CMYA5 PTK2 ADD1 NLRC3 PCLO EXOC8 CPEB4 TENM1 PRKCE RAB15 ROS1 TPPP3 PATJ | 1.64e-03 | 934 | 200 | 19 | GO:0048471 |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.97e-03 | 290 | 200 | 9 | GO:0043292 | |
| GeneOntologyCellularComponent | asymmetric synapse | GAPDH MAPT RTN3 ADD1 AFDN LRRC7 PCLO ITGA8 AKAP9 CPEB4 LRP4 RPL8 | 2.23e-03 | 477 | 200 | 12 | GO:0032279 |
| GeneOntologyCellularComponent | glutamatergic synapse | GAPDH RTN3 ERBIN PTK2 NRP1 EFR3A DIP2A NAE1 LRRC7 PCLO ITGA8 GRM8 PPP1CC PPP2R1B AKAP9 CADPS PRKCE | 2.27e-03 | 817 | 200 | 17 | GO:0098978 |
| GeneOntologyCellularComponent | sarcomere | 2.81e-03 | 249 | 200 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | intercellular canaliculus | 3.14e-03 | 9 | 200 | 2 | GO:0046581 | |
| Domain | ZF_CCHC_HIVEP | 9.76e-05 | 2 | 185 | 2 | PS51811 | |
| Domain | PDZ | 1.32e-04 | 151 | 185 | 8 | PS50106 | |
| Domain | PDZ | 1.39e-04 | 152 | 185 | 8 | IPR001478 | |
| Domain | C2 | 3.32e-04 | 131 | 185 | 7 | PF00168 | |
| Domain | C2 | 4.35e-04 | 137 | 185 | 7 | SM00239 | |
| Domain | PDZ | 5.17e-04 | 141 | 185 | 7 | PF00595 | |
| Domain | LAM_G_DOMAIN | 5.29e-04 | 38 | 185 | 4 | PS50025 | |
| Domain | C2 | 5.40e-04 | 142 | 185 | 7 | PS50004 | |
| Domain | DEK_C | 5.78e-04 | 4 | 185 | 2 | PF08766 | |
| Domain | DEK_C | 5.78e-04 | 4 | 185 | 2 | IPR014876 | |
| Domain | Laminin_G_2 | 6.45e-04 | 40 | 185 | 4 | PF02210 | |
| Domain | PDZ | 6.90e-04 | 148 | 185 | 7 | SM00228 | |
| Domain | CTCK_1 | 6.99e-04 | 18 | 185 | 3 | PS01185 | |
| Domain | - | 7.47e-04 | 150 | 185 | 7 | 2.30.42.10 | |
| Domain | FerI | 9.57e-04 | 5 | 185 | 2 | SM01202 | |
| Domain | FerB | 9.57e-04 | 5 | 185 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 9.57e-04 | 5 | 185 | 2 | IPR012561 | |
| Domain | Ferlin_C | 9.57e-04 | 5 | 185 | 2 | PF16165 | |
| Domain | Ferlin_C | 9.57e-04 | 5 | 185 | 2 | IPR032362 | |
| Domain | - | 9.57e-04 | 5 | 185 | 2 | 2.40.290.10 | |
| Domain | FerIin_dom | 9.57e-04 | 5 | 185 | 2 | IPR012968 | |
| Domain | FerI | 9.57e-04 | 5 | 185 | 2 | PF08151 | |
| Domain | FerB | 9.57e-04 | 5 | 185 | 2 | PF08150 | |
| Domain | Choline_transpo | 9.57e-04 | 5 | 185 | 2 | PF04515 | |
| Domain | Choline_transptr-like | 9.57e-04 | 5 | 185 | 2 | IPR007603 | |
| Domain | SPOC-like_C_dom | 9.57e-04 | 5 | 185 | 2 | IPR016194 | |
| Domain | DMAP_binding | 9.57e-04 | 5 | 185 | 2 | PF06464 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAPT TM7SF3 RTN3 ERBIN ADCY3 CASZ1 PTK2 NRP1 GMPS MRTFB SLC9A7 RPRD2 LRRC7 ARHGEF37 GOLGB1 DIP2B FLNB TIGAR ITCH EPB41L4B CHD9 CEP192 XRCC5 HIVEP3 PPP2R1B TLL1 PRKCE ZFHX3 PATJ ZMYM4 DOP1A RAVER1 | 2.23e-10 | 1489 | 204 | 32 | 28611215 |
| Pubmed | HEXB ATXN2L GAPDH MAPT RTN3 ITGA2 ERBIN ADD1 DIP2A PARP1 AFDN LRRC7 PRRC2B FLNB STRN3 SELENBP1 CLIP2 EPB41L4B IGHV1-69-2 IGHV1-24 IGHV1-18 PCLO IGHV1-3 PPP1CC SLC44A1 KHDRBS1 CADPS CPEB4 PRKCE SSH2 RPL8 | 3.64e-10 | 1431 | 204 | 31 | 37142655 | |
| Pubmed | TRERF1 NCOA3 HIVEP1 ZGRF1 MRTFB AHNAK TADA2A TAF1 MGA GOLGB1 NPAT FLNB ZDBF2 KMT2D LMAN1 ZFHX3 ZMYM4 | 5.52e-10 | 418 | 204 | 17 | 34709266 | |
| Pubmed | ZGRF1 FER1L6 GMPS SLIT2 PARP1 AHNAK GOLGB1 FLNB RBM15 RFC1 KMT2D KHDRBS1 SLC15A1 | 1.54e-09 | 234 | 204 | 13 | 36243803 | |
| Pubmed | TRERF1 NCOA3 ARMCX4 ERBIN PTK2 ADD1 PARP1 SSH1 AFDN LRRC7 HERC2 MGA GOLGB1 PRRC2B DIP2B STRN3 ITCH CLIP2 XRCC5 PPP1CC FRY AKAP9 PRKCE SSH2 | 2.95e-09 | 963 | 204 | 24 | 28671696 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TRERF1 ATXN2L NCOA3 HIVEP1 MAPT CBLC ERBIN ADD1 SSH1 AFDN DIP2B STRN3 RBM15 PARG REST RFC1 MIER1 MYOF KMT2D ZMYM4 RAVER1 | 7.13e-09 | 774 | 204 | 21 | 15302935 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ATXN2L MAPT PTK2 ADD1 BLVRA SLIT2 AHNAK NFX1 AGFG1 EBNA1BP2 MGA PRRC2B EPB41L4B PPP1CC MYOF CPEB4 YTHDF3 AHNAK2 RAVER1 | 6.48e-08 | 724 | 204 | 19 | 36232890 |
| Pubmed | GAPDH ADD1 PARP1 AHNAK RPRD2 RBM15 RFC1 XRCC5 PPP1CC MYOF KHDRBS1 YTHDF3 RAVER1 | 1.28e-07 | 340 | 204 | 13 | 24332808 | |
| Pubmed | Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. | 1.42e-07 | 9 | 204 | 4 | 2578321 | |
| Pubmed | Germline diversity of the expressed BALB/c VhJ558 gene family. | 1.42e-07 | 9 | 204 | 4 | 11483206 | |
| Pubmed | 1.42e-07 | 9 | 204 | 4 | 6789211 | ||
| Pubmed | HEXB ACO1 BTBD1 ARMCX4 CMYA5 PTK2 DIP2A PARP1 SCG2 AFDN TAF1 HERC2 FLNB PMS2 ITCH CLIP2 CHD9 FRY P4HTM KHDRBS1 CADPS HECTD2 LRP4 TBC1D23 ZMYM4 | 1.68e-07 | 1285 | 204 | 25 | 35914814 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L HIVEP1 MAPT ERBIN AHNAK AGFG1 AFDN GOLGB1 DYRK2 DIP2B RBM15 ITCH CEP192 AKAP9 PRKCE SSH2 PATJ DOP1A AHNAK2 KIF1C | 2.05e-07 | 861 | 204 | 20 | 36931259 |
| Pubmed | 2.35e-07 | 10 | 204 | 4 | 3211160 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ATXN2L HIVEP1 GAPDH PARP1 AHNAK AGFG1 AFDN RPRD2 TAF1 EBNA1BP2 MGA NPAT RBM15 ZDBF2 RFC1 XRCC5 EEF1A1P5 PPP1CC KHDRBS1 ZMYM4 YTHDF3 | 2.42e-07 | 954 | 204 | 21 | 36373674 |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | ATXN2L CMYA5 NRP1 PRRC2B RBM15 RFC1 PPP1CC RPL8 YTHDF3 KIF1C RAVER1 | 4.16e-07 | 258 | 204 | 11 | 37794589 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ATXN2L GAPDH ACO1 ERBIN GMPS BLVRA PARP1 MRTFB PLAA SERPINB3 AHNAK NAE1 AFDN GOLGB1 PRRC2B FLNB ITCH RFC1 XRCC5 MYOF PPP2R1B LMAN1 KHDRBS1 MMUT AHNAK2 | 5.28e-07 | 1367 | 204 | 25 | 32687490 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ATXN2L GAPDH ERBIN ADD1 GMPS PARP1 MRTFB AHNAK AGFG1 RPRD2 EBNA1BP2 NOPCHAP1 GOLGB1 PRRC2B STRN3 PARG RFC1 XRCC5 RPL8 AHNAK2 | 7.30e-07 | 934 | 204 | 20 | 33916271 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 7.90e-07 | 220 | 204 | 10 | 35785414 | |
| Pubmed | 7.92e-07 | 4 | 204 | 3 | 17185750 | ||
| Pubmed | Secretoneurin induces airway mucus hypersecretion by enhancing the binding of EGF to NRP1. | 7.92e-07 | 4 | 204 | 3 | 24556756 | |
| Pubmed | ATXN2L GAPDH ERBIN ADD1 MRTFB AHNAK AFDN RPRD2 TAF1 MGA PRRC2B RARS1 KMT2D PATJ ZMYM4 | 1.01e-06 | 549 | 204 | 15 | 38280479 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 NCOA3 HIVEP1 GAPDH TADA2A TAF1 MGA PRRC2B KMT2D ZFHX3 ZMYM4 YTHDF3 | 1.28e-06 | 351 | 204 | 12 | 38297188 |
| Pubmed | ATXN2L GAPDH ERBIN ADD1 GMPS PARP1 EBNA1BP2 MGA RBM15 ITCH RARS1 SELENBP1 CHD9 RFC1 XRCC5 PPP1CC MYOF AKAP9 KHDRBS1 PATJ RPL8 YTHDF3 RAVER1 | 1.35e-06 | 1247 | 204 | 23 | 27684187 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ATXN2L ERBIN ADD1 EFR3A MRTFB AHNAK AGFG1 AFDN LRRC7 EBNA1BP2 GOLGB1 FLNB RARS1 EPB41L4B PATJ | 1.44e-06 | 565 | 204 | 15 | 25468996 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | GAPDH GMPS PARP1 SERPINB3 SERPINB4 RPRD2 MGA PRRC2B RARS1 PPP1CC ZMYM4 RPL8 | 1.52e-06 | 357 | 204 | 12 | 37059091 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GAPDH ERBIN PTK2 GMPS BLVRA PARP1 ALKBH1 PLAA SERPINB3 SERPINB4 AHNAK AFDN EBNA1BP2 HERC2 MGA FLNB RBM15 ITCH RARS1 RFC1 XRCC5 PPP1CC RPL8 AHNAK2 | 1.55e-06 | 1353 | 204 | 24 | 29467282 |
| Pubmed | HIVEP1 GAPDH ACO1 BTBD1 CMYA5 TAF1 MGA FLNB ITCH MYOT LAMA4 PPP1CC AKAP9 ZMYM4 | 1.64e-06 | 497 | 204 | 14 | 23414517 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | ATXN2L HIVEP1 BTBD1 GMPS PARP1 SERPINB4 NAE1 WDR20 HERC2 PRRC2B FLNB STRN3 RBM15 ITCH SELENBP1 CEP192 EXOC8 PPP2R1B UBXN2A ZMYM4 | 2.23e-06 | 1005 | 204 | 20 | 19615732 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ATXN2L GAPDH RTN3 ITGA2 CASZ1 ZNF518A PARP1 AHNAK AFDN EBNA1BP2 MGA GOLGB1 RARS1 XRCC5 EXOC8 ZNF28 P4HTM LMAN1 TBC1D23 SLC29A1 ZMYM4 RPL8 | 2.67e-06 | 1203 | 204 | 22 | 29180619 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | ATXN2L EFR3A AHNAK WDR20 GOLGB1 FLNB RARS1 ZDBF2 MYOF AHNAK2 | 3.09e-06 | 256 | 204 | 10 | 33397691 |
| Pubmed | 3.30e-06 | 18 | 204 | 4 | 6788376 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.48e-06 | 203 | 204 | 9 | 22083510 | |
| Pubmed | ERBIN NFX1 LRRC7 GOLGB1 PRRC2B EPB41L4B KHDRBS1 CPEB4 TENM1 AHNAK2 | 3.92e-06 | 263 | 204 | 10 | 34702444 | |
| Pubmed | TRERF1 NCOA3 HIVEP1 ERBIN WDR20 RPRD2 TADA2A TAF1 EBNA1BP2 HERC2 MGA PRRC2B NPAT RARS1 CEP192 RFC1 XRCC5 MIER1 KMT2D KHDRBS1 ZFHX3 ZMYM4 YTHDF3 RAVER1 | 3.94e-06 | 1429 | 204 | 24 | 35140242 | |
| Pubmed | ATXN2L GAPDH MAPT RTN3 PALMD ERBIN GMPS PLAA AFDN LRRC7 FLNB STRN3 RARS1 PCLO ACBD5 ZDBF2 PPP1CC CADPS CPEB4 TENM1 RPL8 | 4.03e-06 | 1139 | 204 | 21 | 36417873 | |
| Pubmed | ERBIN EFR3A GMPS PARP1 SSH1 AHNAK WDR20 HERC2 PRRC2B RBM15 PMS2 ACBD5 CEP192 PPP1CC KMT2D LMAN1 AKAP9 SSH2 SLC29A1 RAVER1 | 4.23e-06 | 1049 | 204 | 20 | 27880917 | |
| Pubmed | TRERF1 NCOA3 HIVEP1 CASZ1 RPRD2 TAF1 MGA PRRC2B KMT2D RAVER1 | 4.63e-06 | 268 | 204 | 10 | 33640491 | |
| Pubmed | ATXN2L GAPDH ERBIN ADD1 EFR3A GMPS PARP1 AHNAK AFDN LRRC7 GOLGB1 FLNB XRCC5 LMAN1 PATJ RPL8 | 5.02e-06 | 708 | 204 | 16 | 39231216 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | GAPDH ACO1 RTN3 PARP1 AHNAK FLNB RARS1 SELENBP1 PCLO XRCC5 HIVEP3 MYOF AKAP9 KHDRBS1 ZFHX3 RPL8 AHNAK2 | 6.37e-06 | 807 | 204 | 17 | 30575818 |
| Pubmed | SYNPO2 HIVEP1 ERBIN PTK2 AGFG1 TAF1 HERC2 MGA GOLGB1 CLIP2 LAMA4 KHDRBS1 PRKCE | 6.78e-06 | 486 | 204 | 13 | 20936779 | |
| Pubmed | GBP7 ERBIN ADCY3 PLAA NFX1 MGA GOLGB1 NPAT FLNB PMS2 EPB41L4B AKNAD1 CEP192 MIER1 ESCO2 SLC44A1 ACCSL PATJ SLC29A1 YTHDF3 | 6.85e-06 | 1084 | 204 | 20 | 11544199 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 7.47e-06 | 283 | 204 | 10 | 30585729 | |
| Pubmed | ATXN2L GAPDH GMPS PARP1 AHNAK EBNA1BP2 FLNB RARS1 CHD9 XRCC5 KHDRBS1 RPL8 YTHDF3 | 8.07e-06 | 494 | 204 | 13 | 26831064 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 8.29e-06 | 171 | 204 | 8 | 20201926 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ATXN2L HIVEP1 ZGRF1 RTN3 MRTFB AGFG1 GOLGB1 PRRC2B RBM15 ZDBF2 CEP192 PATJ ZMYM4 YTHDF3 | 1.12e-05 | 588 | 204 | 14 | 38580884 |
| Pubmed | HIVEP1 ERBIN ZNF518A MRTFB AFDN HERC2 MGA GOLGB1 FLNB L1TD1 LAMA4 PPP1CC KMT2D KHDRBS1 | 1.18e-05 | 591 | 204 | 14 | 15231748 | |
| Pubmed | ATXN2L GAPDH GMPS PARP1 EBNA1BP2 MGA RBM15 RFC1 XRCC5 EEF1A1P5 KHDRBS1 RPL8 | 1.30e-05 | 441 | 204 | 12 | 31239290 | |
| Pubmed | GAPDH ERBIN ADD1 DMXL1 AHNAK WDR20 AFDN EBNA1BP2 MGA GOLGB1 PRRC2B EPB41L4B ACBD5 CEP192 ZFHX3 RPL8 | 1.59e-05 | 777 | 204 | 16 | 35844135 | |
| Pubmed | ATXN2L GAPDH ACO1 CMYA5 PARP1 STRN3 RARS1 XRCC5 EEF1A1P5 ZNF28 KHDRBS1 RAVER1 | 1.62e-05 | 451 | 204 | 12 | 36168627 | |
| Pubmed | Pellino1 specifically binds to phospho-Thr18 of p53 and is recruited to sites of DNA damage. | 1.63e-05 | 9 | 204 | 3 | 30987826 | |
| Pubmed | ATXN2L GAPDH PARP1 AHNAK NAE1 AGFG1 EBNA1BP2 FLNB RFC1 XRCC5 EEF1A1P5 RPL8 AHNAK2 | 1.98e-05 | 538 | 204 | 13 | 28524877 | |
| Pubmed | HEXB ATXN2L GAPDH ADCY3 PARP1 AHNAK HERC2 GOLGB1 DIP2B ITCH RARS1 ACBD5 XRCC5 EXOC8 SLC44A1 SYNE3 LMAN1 KHDRBS1 SLC29A1 RPL8 | 2.01e-05 | 1168 | 204 | 20 | 19946888 | |
| Pubmed | ATXN2L GAPDH ADD1 NRP1 PARP1 AHNAK NFX1 EBNA1BP2 HERC2 PRRC2B RBM15 RARS1 CLIP2 RFC1 XRCC5 PPP1CC ESCO2 AKAP9 CPEB4 ROS1 MUC5AC YTHDF3 | 2.06e-05 | 1371 | 204 | 22 | 36244648 | |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | ATXN2L ADCY3 NAE1 DIP2B RFC1 XRCC5 PPP1CC AKAP9 KHDRBS1 MMUT | 2.22e-05 | 321 | 204 | 10 | 32098917 |
| Pubmed | Coordination of endothelial cell positioning and fate specification by the epicardium. | 2.31e-05 | 10 | 204 | 3 | 34230480 | |
| Pubmed | 2.31e-05 | 10 | 204 | 3 | 10742111 | ||
| Pubmed | BAG1 RTN3 ERBIN ADD1 DMXL1 EFR3A DIP2A PARP1 NAE1 EBNA1BP2 HERC2 GOLGB1 NPAT TIGAR ITCH ACBD5 CEP192 XRCC5 PPP1CC SYNE3 LMAN1 AKAP9 RPL8 | 2.35e-05 | 1487 | 204 | 23 | 33957083 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | CISD1 RTN3 ARMCX4 BLVRA DIP2A PARP1 NFX1 EBNA1BP2 HERC2 GOLGB1 PRRC2B DIP2B STRN3 PCLO ACBD5 ZDBF2 XRCC5 LMAN1 AKAP9 KHDRBS1 MMUT AHNAK2 RAVER1 | 2.58e-05 | 1496 | 204 | 23 | 32877691 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA3 HIVEP1 CASZ1 ZNF518A GMPS PARP1 TAF1 MGA PCLO KMT2D RPL8 | 2.60e-05 | 398 | 204 | 11 | 35016035 |
| Pubmed | HEXB GAPDH BAG1 RTN3 GMPS BLVRA PARP1 AHNAK EBNA1BP2 PRRC2B FLNB ITCH RARS1 RFC1 XRCC5 PPP1CC MYOF P4HTM LMAN1 YTHDF3 RAVER1 | 2.81e-05 | 1297 | 204 | 21 | 33545068 | |
| Pubmed | TRERF1 ATXN2L NCOA3 HIVEP1 GAPDH BAG1 GMPS PARP1 NAE1 PRRC2B RBM15 RARS1 CHD9 RFC1 KMT2D LMAN1 KHDRBS1 ZMYM4 RAVER1 | 3.01e-05 | 1103 | 204 | 19 | 34189442 | |
| Pubmed | HEXB MAPT ECHDC1 ERBIN SLIT2 NFX1 AGFG1 NOPCHAP1 GOLGB1 PRRC2B BLZF1 PPP1CC LMAN1 KHDRBS1 TBC1D23 ZMYM4 YTHDF3 RAVER1 | 3.05e-05 | 1007 | 204 | 18 | 34597346 | |
| Pubmed | 3.18e-05 | 335 | 204 | 10 | 15741177 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 3.20e-05 | 268 | 204 | 9 | 33024031 | |
| Pubmed | Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure. | 3.42e-05 | 2 | 204 | 2 | 23354406 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 10488067 | ||
| Pubmed | Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. | 3.42e-05 | 2 | 204 | 2 | 21705081 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 10552998 | ||
| Pubmed | Genetic dissection of the function of mammalian P-glycoproteins. | 3.42e-05 | 2 | 204 | 2 | 9196326 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 12531386 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 32054995 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 19812418 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 25012650 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 27177126 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 8898203 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 2473069 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 19185004 | ||
| Pubmed | SCCA2-like serpins mediate genetic predisposition to skin tumors. | 3.42e-05 | 2 | 204 | 2 | 12702576 | |
| Pubmed | Lysoptosis is an evolutionarily conserved cell death pathway moderated by intracellular serpins. | 3.42e-05 | 2 | 204 | 2 | 35022507 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 23254695 | ||
| Pubmed | Regulation of ALT-associated homology-directed repair by polyADP-ribosylation. | 3.42e-05 | 2 | 204 | 2 | 33046907 | |
| Pubmed | Squamous cell carcinoma antigen production in nasal inverted papilloma. | 3.42e-05 | 2 | 204 | 2 | 23168150 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 10653592 | ||
| Pubmed | Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice. | 3.42e-05 | 2 | 204 | 2 | 9473291 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 29112685 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 10956412 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 2471060 | ||
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 35874657 | ||
| Pubmed | Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy. | 3.42e-05 | 2 | 204 | 2 | 27668655 | |
| Pubmed | MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells. | 3.42e-05 | 2 | 204 | 2 | 18231753 | |
| Pubmed | LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII. | 3.42e-05 | 2 | 204 | 2 | 14629470 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 22454210 | ||
| Pubmed | ABCB1/4 gallbladder cancer risk variants identified in India also show strong effects in Chileans. | 3.42e-05 | 2 | 204 | 2 | 32058310 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 27037060 | ||
| Pubmed | PARP1 gene expression is downregulated by knockdown of PARG gene. | 3.42e-05 | 2 | 204 | 2 | 23467693 | |
| Pubmed | 3.42e-05 | 2 | 204 | 2 | 3768958 | ||
| Pubmed | Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice. | 3.42e-05 | 2 | 204 | 2 | 38522903 | |
| Pubmed | Localization of the human multiple drug resistance gene, MDR1, to 7q21.1. | 3.42e-05 | 2 | 204 | 2 | 3477522 | |
| Pubmed | Subcellular localization of ATBF1 regulates MUC5AC transcription in gastric cancer. | 3.42e-05 | 2 | 204 | 2 | 17330845 | |
| Interaction | PHF21A interactions | HIVEP1 ZGRF1 MRTFB AHNAK TADA2A TAF1 MGA GOLGB1 NPAT FLNB ZDBF2 ESCO2 KMT2D LMAN1 ZFHX3 | 1.62e-06 | 343 | 198 | 15 | int:PHF21A |
| Interaction | OR10H1 interactions | 8.20e-06 | 49 | 198 | 6 | int:OR10H1 | |
| Cytoband | 14q32.33 | IGHV5-10-1 IGHV5-51 IGHV1-69-2 IGHV1-46 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3 IGHV1-2 IGHV7-4-1 AHNAK2 | 7.46e-09 | 228 | 204 | 11 | 14q32.33 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q32 | WDR20 IGHV5-10-1 IGHV5-51 IGHV1-69-2 IGHV1-46 IGHV1-24 IGHV1-18 IGHV1-3 IGHV1-2 SYNE3 IGHV7-4-1 AHNAK2 | 1.01e-05 | 566 | 204 | 12 | chr14q32 |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | IGHV5-10-1 IGHV5-51 IGHV1-69-2 IGHV1-46 IGHV1-24 IGHV1-18 IGHV1-8 IGHV1-3 IGHV1-2 IGHV7-4-1 | 1.42e-06 | 187 | 135 | 10 | 349 |
| GeneFamily | PDZ domain containing | 1.87e-05 | 152 | 135 | 8 | 1220 | |
| GeneFamily | Slingshot protein phosphatases | 1.65e-04 | 3 | 135 | 2 | 898 | |
| GeneFamily | Ferlin family | 8.14e-04 | 6 | 135 | 2 | 828 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TRERF1 ATXN2L NCOA3 GAPDH MGAT4A GBP2 BTBD1 ERBIN ADD1 ABCB1 EFR3A DIP2A PARP1 SSH1 AHNAK AGFG1 NLRC3 PRRC2B DYRK2 NPAT REST XRCC5 MIER1 PPP1CC HIVEP3 KMT2D AKAP9 KHDRBS1 LPIN2 SSH2 | 1.28e-06 | 1492 | 201 | 30 | M40023 |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 5.21e-06 | 164 | 201 | 9 | M41676 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | IL36B MAPT ADD1 NRP1 EBNA1BP2 ZNF614 GOLGB1 DIP2B ITCH ANK1 MCTP1 SLIT3 PRKCE | 2.21e-05 | 417 | 201 | 13 | M39224 |
| Coexpression | GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_UP | 2.56e-05 | 200 | 201 | 9 | M5997 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP | 2.56e-05 | 200 | 201 | 9 | M8087 | |
| Coexpression | GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN | 2.56e-05 | 200 | 201 | 9 | M3508 | |
| Coexpression | GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP | 2.56e-05 | 200 | 201 | 9 | M7195 | |
| Coexpression | GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP | 2.56e-05 | 200 | 201 | 9 | M7352 | |
| Coexpression | GSE34515_CD16_POS_MONOCYTE_VS_DC_UP | 2.56e-05 | 200 | 201 | 9 | M8765 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_UP | 3.00e-05 | 157 | 201 | 8 | M7731 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA3 HIVEP1 PTK2 EFR3A GMPS SLIT2 GLRB AGFG1 NPAT FLNB STRN3 ITCH PARG CHD9 MYOF AKAP9 ZFHX3 ZMYM4 YTHDF3 | 3.56e-05 | 856 | 201 | 19 | M4500 |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3 | 3.74e-05 | 25 | 201 | 4 | MM870 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CASZ1 SLC9A7 LRRC7 CEP126 PRRC2B DYRK2 DIP2B ANK1 PCLO ITGA8 HIVEP3 FRY ZNF28 AKAP9 CADPS TLL1 CPEB4 TENM1 ZFHX3 SSH2 DOP1A AHNAK2 | 4.44e-05 | 1106 | 201 | 22 | M39071 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN | ADD1 ZNF518A ZNF599 MRTFB SLC9A7 AFDN NOPCHAP1 GOLGB1 FLNB SELENBP1 EPB41L4B LAMA4 CHD9 SIDT2 AKAP9 ZFHX3 PATJ SLC29A1 | 5.41e-05 | 807 | 201 | 18 | M16651 |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN | 8.85e-05 | 183 | 201 | 8 | M8189 | |
| Coexpression | GSE14350_IL2RB_KO_VS_WT_TREG_UP | 1.58e-04 | 199 | 201 | 8 | M3421 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN | 1.58e-04 | 199 | 201 | 8 | M7711 | |
| Coexpression | GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP | 1.58e-04 | 199 | 201 | 8 | M7710 | |
| Coexpression | GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN | 1.58e-04 | 199 | 201 | 8 | M6605 | |
| Coexpression | GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 1.63e-04 | 200 | 201 | 8 | M9496 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP | 1.63e-04 | 200 | 201 | 8 | M8030 | |
| Coexpression | GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN | 1.63e-04 | 200 | 201 | 8 | M8056 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN | 1.63e-04 | 200 | 201 | 8 | M8278 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP | 1.63e-04 | 200 | 201 | 8 | M3869 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP | 1.63e-04 | 200 | 201 | 8 | M7342 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP | 1.63e-04 | 200 | 201 | 8 | M6584 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | SCG2 SLC9A7 LRRC7 ANK1 EPB41L4B GRM8 HIVEP3 FRY AKAP9 CADPS CPEB4 TENM1 ZFHX3 SSH2 | 1.79e-04 | 584 | 201 | 14 | M39068 |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | GAPDH CBLC ITGA2 SERPINB3 SERPINB4 AHNAK FLNB COL7A1 MYOF GRHL3 AHNAK2 | 1.99e-09 | 197 | 204 | 11 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | GAPDH CBLC ITGA2 SERPINB3 SERPINB4 AHNAK FLNB COL7A1 MYOF GRHL3 AHNAK2 | 1.99e-09 | 197 | 204 | 11 | fb272c9c60ee3d980e528044dc567b4925a23da6 |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-08 | 197 | 204 | 10 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | GAPDH CBLC ITGA2 SERPINB3 SERPINB4 FLNB COL7A1 MYOF GRHL3 AHNAK2 | 2.71e-08 | 197 | 204 | 10 | dcabea5c50c133c9a4e294e447462d0393174ea7 |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-08 | 197 | 204 | 10 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.61e-08 | 168 | 204 | 9 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-07 | 175 | 204 | 9 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-07 | 176 | 204 | 9 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-07 | 177 | 204 | 9 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-07 | 177 | 204 | 9 | 57033ee0d49a4a50fc25328a4a44d4de2b35f505 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-07 | 178 | 204 | 9 | 431e7557b8e8764e16e9e48368ce6bfa3c61561a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-07 | 179 | 204 | 9 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-07 | 180 | 204 | 9 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-07 | 183 | 204 | 9 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | GAPDH ITGA2 CMYA5 MRTFB SERPINB3 SERPINB4 AHNAK COL7A1 AHNAK2 | 1.96e-07 | 185 | 204 | 9 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.15e-07 | 187 | 204 | 9 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGHV5-51 IGHV1-69-2 IGHV1-46 IGHV1-24 IGHV1-18 IGHV1-3 IGHV1-2 LMAN1 IGHV7-4-1 | 2.45e-07 | 190 | 204 | 9 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGHV5-51 IGHV1-69-2 IGHV1-46 IGHV1-24 IGHV1-18 IGHV1-3 IGHV1-2 LMAN1 IGHV7-4-1 | 2.45e-07 | 190 | 204 | 9 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.80e-07 | 193 | 204 | 9 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-07 | 194 | 204 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-07 | 195 | 204 | 9 | 7e0ef92059ff34e368d2324815f49b50e3ca7332 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 3.33e-07 | 197 | 204 | 9 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-07 | 197 | 204 | 9 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-07 | 197 | 204 | 9 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.48e-07 | 198 | 204 | 9 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.48e-07 | 198 | 204 | 9 | 22935a8afac54021f68b5f7a5accf51523e2f336 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.78e-07 | 200 | 204 | 9 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.78e-07 | 200 | 204 | 9 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.78e-07 | 200 | 204 | 9 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.78e-07 | 200 | 204 | 9 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SYNPO2 SLIT2 COL24A1 SCN7A CEP126 ITGA8 LAMA4 TENM1 ADAMTS14 | 3.78e-07 | 200 | 204 | 9 | fb53be20392a8309a7393774c774a1b1aec6e676 |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.78e-07 | 200 | 204 | 9 | 1b485ff2435c6732be58cbc9eb2f5c273f9c4bf2 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.78e-07 | 200 | 204 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.78e-07 | 200 | 204 | 9 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.77e-07 | 154 | 204 | 8 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.11e-06 | 168 | 204 | 8 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-06 | 170 | 204 | 8 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.39e-06 | 173 | 204 | 8 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-06 | 174 | 204 | 8 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-06 | 176 | 204 | 8 | 72a2a01618ce836bc843395d5095e9090759b4a6 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.87e-06 | 180 | 204 | 8 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-06 | 181 | 204 | 8 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.29e-06 | 185 | 204 | 8 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.48e-06 | 187 | 204 | 8 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-06 | 187 | 204 | 8 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-06 | 187 | 204 | 8 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-06 | 187 | 204 | 8 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | P15-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.58e-06 | 188 | 204 | 8 | c0a03e33027f52b5c25ffbc8f822128e5160ed20 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.68e-06 | 189 | 204 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.68e-06 | 189 | 204 | 8 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.79e-06 | 190 | 204 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 2.79e-06 | 190 | 204 | 8 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.90e-06 | 191 | 204 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.90e-06 | 191 | 204 | 8 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.02e-06 | 192 | 204 | 8 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.02e-06 | 192 | 204 | 8 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.13e-06 | 193 | 204 | 8 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.13e-06 | 193 | 204 | 8 | 7c34abdcb8839b9fb25457a79af6c5e7b9714b21 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.13e-06 | 193 | 204 | 8 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.13e-06 | 193 | 204 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.13e-06 | 193 | 204 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.26e-06 | 194 | 204 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 3.38e-06 | 195 | 204 | 8 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.65e-06 | 197 | 204 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 3.65e-06 | 197 | 204 | 8 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.65e-06 | 197 | 204 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.79e-06 | 198 | 204 | 8 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.79e-06 | 198 | 204 | 8 | 89ec1e760a193441092571475cc66a3b425f232e | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.93e-06 | 199 | 204 | 8 | 974f71b56f66243c78f2f297a1540e0e186df530 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-06 | 199 | 204 | 8 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.93e-06 | 199 | 204 | 8 | ba284f984909504221900bca5ea12ada5b2ffd9f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.93e-06 | 199 | 204 | 8 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.93e-06 | 199 | 204 | 8 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.08e-06 | 200 | 204 | 8 | e3051dcf9b5c8e4dc71a8080b7a7aafea46f2b2b | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.08e-06 | 200 | 204 | 8 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.08e-06 | 200 | 204 | 8 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.08e-06 | 200 | 204 | 8 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 4.08e-06 | 200 | 204 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.08e-06 | 200 | 204 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.08e-06 | 200 | 204 | 8 | 0f6620a5baace704518d42fa2f3f90751240f7dd | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 4.08e-06 | 200 | 204 | 8 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.08e-06 | 200 | 204 | 8 | 1ce9599cc9d8158e8842ca56f35fa7809c234849 | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.08e-06 | 200 | 204 | 8 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO---L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.08e-06 | 200 | 204 | 8 | 7b845aabfbdfe893acc9334a5707833761bed60b | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-06 | 200 | 204 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.08e-06 | 200 | 204 | 8 | 0638273fc0910f47fe7a0b6d9a8639b0e9976d13 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.08e-06 | 200 | 204 | 8 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.00e-05 | 162 | 204 | 7 | 58da6bc04cdac0002b0e6a751c96ff95e1a7f70f | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 163 | 204 | 7 | 299ac2463b7f58eee419d822a2a2d64b973d87e9 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 1.08e-05 | 164 | 204 | 7 | 3b6a32ba53d05f6818fe950ac426f489383b645a | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.32e-05 | 169 | 204 | 7 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_CPZ|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-05 | 170 | 204 | 7 | 021c3e45955d18e241f7d98acdf22076fee4fc43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 171 | 204 | 7 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| Disease | Colorectal Carcinoma | GAPDH ABCB1 ABCB4 PARP1 WNT16 ETAA1 COL7A1 PMS2 MYOT SELENBP1 HIVEP3 PPP2R1B AKAP9 TENM1 PRKCE SLC29A1 ZMYM4 HDC | 1.02e-06 | 702 | 194 | 18 | C0009402 |
| Disease | venous thromboembolism, fibrinogen measurement | 8.10e-05 | 67 | 194 | 5 | EFO_0004286, EFO_0004623 | |
| Disease | body weight | ATXN2L HIVEP1 CBLC EFR3A SLIT2 MGA NDNF EPB41L4B SPATA31C2 SLC44A2 ATP13A5 CEP192 CADPS TLL1 CPEB4 SLIT3 PRKCE ZFHX3 ADAMTS14 PATJ | 2.60e-04 | 1261 | 194 | 20 | EFO_0004338 |
| Disease | arecaidine measurement | 4.24e-04 | 5 | 194 | 2 | EFO_0801112 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 4.24e-04 | 5 | 194 | 2 | DOID:3030 (is_marker_for) | |
| Disease | autism spectrum disorder symptom | 4.50e-04 | 23 | 194 | 3 | EFO_0005426 | |
| Disease | Ischemic stroke, fibrinogen measurement | 4.75e-04 | 55 | 194 | 4 | EFO_0004623, HP_0002140 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 5.45e-04 | 57 | 194 | 4 | DOID:10652 (implicated_via_orthology) | |
| Disease | neurotic disorder | 5.55e-04 | 101 | 194 | 5 | EFO_0004257 | |
| Disease | reticulocyte count | MAPT ADCY3 ABCB4 NRP1 AHNAK WDR20 FLNB ANK1 SLC44A2 LAMA4 REST RFC1 TSBP1 CPEB4 PRKCE UBXN2A KIF1C | 5.74e-04 | 1045 | 194 | 17 | EFO_0007986 |
| Disease | Paroxysmal atrial fibrillation | 6.00e-04 | 156 | 194 | 6 | C0235480 | |
| Disease | familial atrial fibrillation | 6.00e-04 | 156 | 194 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 6.00e-04 | 156 | 194 | 6 | C2585653 | |
| Disease | Atrial Fibrillation | 6.86e-04 | 160 | 194 | 6 | C0004238 | |
| Disease | Malignant neoplasm of breast | TRERF1 NCOA3 BAG1 NME8 ABCB1 PARP1 LRRC7 HERC2 GOLGB1 FLNB COL7A1 ANK1 KMT2D AKAP9 TLL1 TENM1 DOP1A | 7.77e-04 | 1074 | 194 | 17 | C0006142 |
| Disease | atrial fibrillation | 8.27e-04 | 371 | 194 | 9 | EFO_0000275 | |
| Disease | response to interferon-beta | 8.84e-04 | 7 | 194 | 2 | GO_0035456 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 8.84e-04 | 7 | 194 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | breast carcinoma (is_marker_for) | 9.50e-04 | 66 | 194 | 4 | DOID:3459 (is_marker_for) | |
| Disease | Cardiomyopathies, Primary | 1.12e-03 | 69 | 194 | 4 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 1.12e-03 | 69 | 194 | 4 | C0036529 | |
| Disease | cortical thickness | MAPT TM7SF3 BTBD1 NRP1 ENO4 SLIT2 WNT16 EBNA1BP2 DIP2B FLNB STRN3 FBXW10 PCDHB11 CADPS CPEB4 LRP4 SSH2 | 1.15e-03 | 1113 | 194 | 17 | EFO_0004840 |
| Disease | pneumococcal meningitis | 1.17e-03 | 8 | 194 | 2 | EFO_1001114 | |
| Disease | Hereditary spherocytosis | 1.17e-03 | 8 | 194 | 2 | C0037889 | |
| Disease | cervix carcinoma (is_marker_for) | 1.17e-03 | 8 | 194 | 2 | DOID:2893 (is_marker_for) | |
| Disease | waist-hip ratio | MAPT ADCY3 NRP1 COL24A1 AHNAK ETAA1 EPB41L4B LAMA4 CEP192 PPP2R1B SLC44A1 P4HTM CADPS CPEB4 RAB15 TBC1D23 PATJ ZMYM4 | 1.28e-03 | 1226 | 194 | 18 | EFO_0004343 |
| Disease | brain connectivity measurement | 1.39e-03 | 400 | 194 | 9 | EFO_0005210 | |
| Disease | gallbladder neoplasm | 1.50e-03 | 9 | 194 | 2 | EFO_0004606 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.50e-03 | 9 | 194 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | alcohol dependence (implicated_via_orthology) | 1.50e-03 | 9 | 194 | 2 | DOID:0050741 (implicated_via_orthology) | |
| Disease | apolipoprotein B measurement | CBLC CASZ1 PTK2 ABCB1 ABCB4 MYBPHL ANK1 AKNAD1 SLC44A2 MYOF SIDT2 ZFHX3 | 1.55e-03 | 663 | 194 | 12 | EFO_0004615 |
| Disease | Cardiomyopathies | 1.72e-03 | 130 | 194 | 5 | C0878544 | |
| Disease | response to carboplatin, response to antineoplastic agent | 1.87e-03 | 10 | 194 | 2 | GO_0097327, GO_0097328 | |
| Disease | age of onset of depressive disorder, wellbeing measurement | 1.87e-03 | 10 | 194 | 2 | EFO_0007869, OBA_2040166 | |
| Disease | maleate measurement, Alpha ketoglutarate measurement, fumarate measurement | 2.27e-03 | 11 | 194 | 2 | EFO_0010457, EFO_0010480, EFO_0010509 | |
| Disease | cataract | 2.45e-03 | 141 | 194 | 5 | MONDO_0005129 | |
| Disease | Colorectal Neoplasms | 2.47e-03 | 277 | 194 | 7 | C0009404 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 3.20e-03 | 13 | 194 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | rhinitis (biomarker_via_orthology) | 3.20e-03 | 13 | 194 | 2 | DOID:4483 (biomarker_via_orthology) | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.24e-03 | 45 | 194 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 3.24e-03 | 45 | 194 | 3 | DOID:3525 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | HEXB ATXN2L MAPT NRP1 BLVRA SLIT2 COL24A1 AGFG1 FLNB STRN3 ITCH REST CADPS TLL1 CPEB4 ZFHX3 SSH2 TNXB | 3.47e-03 | 1345 | 194 | 18 | EFO_0010736 |
| Disease | disease progression measurement, Crohn's disease | 3.67e-03 | 47 | 194 | 3 | EFO_0000384, EFO_0008336 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 3.72e-03 | 14 | 194 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | cortical surface area measurement, neuroimaging measurement | 4.01e-03 | 227 | 194 | 6 | EFO_0004346, EFO_0010736 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 4.13e-03 | 49 | 194 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | Down syndrome (implicated_via_orthology) | 4.27e-03 | 15 | 194 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | glycerate measurement | 4.27e-03 | 15 | 194 | 2 | EFO_0021029 | |
| Disease | corpus callosum volume measurement | 4.35e-03 | 100 | 194 | 4 | EFO_0010299 | |
| Disease | QRS amplitude, QRS complex | 4.37e-03 | 50 | 194 | 3 | EFO_0005054, EFO_0007742 | |
| Disease | reaction time measurement | MAPT EFR3A COL24A1 GPX6 ITGA8 CEP192 KMT2D MCTP1 LRP4 PRKCE ZFHX3 | 4.38e-03 | 658 | 194 | 11 | EFO_0008393 |
| Disease | epilepsy (implicated_via_orthology) | 4.55e-03 | 163 | 194 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | telomere length | 4.83e-03 | 313 | 194 | 7 | EFO_0004505 | |
| Disease | Intrahepatic cholestasis of pregnancy | 4.86e-03 | 16 | 194 | 2 | EFO_0009048 | |
| Disease | T-Cell Lymphoma | 4.86e-03 | 16 | 194 | 2 | C0079772 | |
| Disease | Pontoneocerebellar hypoplasia | 4.86e-03 | 16 | 194 | 2 | cv:C1261175 | |
| Disease | corpus callosum posterior volume measurement | 4.88e-03 | 52 | 194 | 3 | EFO_0010298 | |
| Disease | neuroimaging measurement | ATXN2L CISD1 MAPT PTK2 NRP1 ENO4 SLIT2 COL24A1 WNT16 DIP2B STRN3 ITCH CADPS CPEB4 SSH2 | 4.88e-03 | 1069 | 194 | 15 | EFO_0004346 |
| Disease | Huntington's disease (is_marker_for) | 5.15e-03 | 53 | 194 | 3 | DOID:12858 (is_marker_for) | |
| Disease | Small cell carcinoma of lung | 5.43e-03 | 54 | 194 | 3 | C0149925 | |
| Disease | Mouth Neoplasms | 5.43e-03 | 54 | 194 | 3 | C0026640 | |
| Disease | Peripheral Nervous System Diseases | 5.43e-03 | 54 | 194 | 3 | C4721453 | |
| Disease | Malignant neoplasm of mouth | 5.43e-03 | 54 | 194 | 3 | C0153381 | |
| Disease | Inborn Errors of Metabolism | 5.48e-03 | 17 | 194 | 2 | C0025521 | |
| Disease | Astrocytosis | 5.48e-03 | 17 | 194 | 2 | C3887640 | |
| Disease | Gliosis | 5.48e-03 | 17 | 194 | 2 | C0017639 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 6.01e-03 | 56 | 194 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | borna disease (biomarker_via_orthology) | 6.14e-03 | 18 | 194 | 2 | DOID:5154 (biomarker_via_orthology) | |
| Disease | aortic measurement | 6.49e-03 | 251 | 194 | 6 | EFO_0020865 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KPEVLGAQEKNTGTN | 811 | Q8NAT2 | |
| EGKKVRGLVLINPQN | 316 | Q4AC99 | |
| EKEPLGVNAKGQQVF | 571 | P21399 | |
| NALQGEVKPVLQKLG | 566 | P30154 | |
| QSNGPEKQEKEGVIQ | 141 | P55196 | |
| SKLLQPGDKIIQANG | 1366 | Q96RT1 | |
| LQKLTGQQGEEPSLV | 3561 | Q99996 | |
| QLVENQETGPGKKEI | 761 | Q4VNC0 | |
| NKPLSQVLLEGQKDG | 291 | Q9ULV8 | |
| GPGAQKVIKSQLNVS | 56 | Q13686 | |
| IQKLKTGENLRPQNG | 316 | Q86V15 | |
| GQPVTILEAQDKKGN | 626 | A1IGU5 | |
| VKPIDENLGQTGKSA | 266 | Q5T8D3 | |
| ELSGNLVPVKKAAQQ | 1296 | P16157 | |
| DVEKAQKQGQLETPG | 781 | Q5XX13 | |
| TKQGKTAAPELGQNV | 1036 | Q5XX13 | |
| DVKEANKQRGQAGPQ | 241 | Q5T5M9 | |
| NKELTGIQQGFLPKD | 251 | Q99933 | |
| DINAPDVEVQGKVKG | 3386 | Q09666 | |
| NSGPGAQQKEIGELK | 636 | Q9UDT6 | |
| QVQLITSKGNGEKPL | 1046 | Q5JWR5 | |
| GQEVQKGPAVEIAKL | 671 | Q9UI46 | |
| DLAIQQGKQKPSGLT | 556 | Q9Y485 | |
| GEPKLQVLGTNSFVK | 111 | Q14156 | |
| LLGTKNKVKGNPNVV | 641 | Q5H9R4 | |
| LPGARNKVKGNSNVV | 881 | Q5H9R4 | |
| VKNQVTGSFILNPKG | 756 | Q8WXS8 | |
| IAGKVPGLQNEQKRF | 526 | Q8WWM7 | |
| NVSALPKGFGVQELK | 351 | Q9BUB4 | |
| PKGFGVQELKILQSD | 356 | Q9BUB4 | |
| KGNLRVKPQQGTAVF | 406 | Q9NXG6 | |
| PEGVQKILIGNKADE | 111 | P59190 | |
| LQLALQTQGQKKPGI | 381 | Q8IY67 | |
| LPVGGNKDKENTGVL | 906 | Q96T37 | |
| IKLEKPQEQTVSEGG | 191 | Q9H0N0 | |
| IKLEKPQEQTVSEGG | 191 | Q53S08 | |
| LIEQKGEKPNGEINS | 296 | Q5T6V5 | |
| GQDEEAVKKLTVNPG | 646 | P09874 | |
| PVLQGLSLEVKKGQT | 1051 | P08183 | |
| TGEALNVIPGAQEKK | 186 | Q14207 | |
| KVNIKFSNEQGLPGS | 496 | Q6IE37 | |
| QKLNAKGGNVPQLDA | 636 | Q9ULU8 | |
| GAGDDPVQARKIIKQ | 511 | P19113 | |
| LKNEGSLQPAVQIGN | 116 | Q9UM21 | |
| PNFQERIKIKTNGLG | 281 | Q9NP74 | |
| KLLNTGEGNKEAPLQ | 881 | Q13127 | |
| KPTANIILNGQKLEA | 636 | O00370 | |
| KVAIPLLSIQNGEQK | 706 | Q6DN14 | |
| VQLVQSGAEVKKPGE | 21 | A0A0J9YXX1 | |
| GQEKGKASPRIEQVA | 376 | Q7RTR2 | |
| LGNVGINNQKKIPST | 311 | Q9H2G9 | |
| VILKQPGNGKTDQGI | 26 | Q8IWI9 | |
| NNALQVLPGSIGKLK | 216 | Q96NW7 | |
| LGKIPGNLSEEFKQV | 46 | A6NDA9 | |
| EEVKKTLQQFPGGSI | 41 | Q9NTX5 | |
| VNRKPTLVQGLEGQK | 3296 | O95714 | |
| VQLVQSGAEVKKPGA | 21 | P01743 | |
| AGLKKQETPDQVGSQ | 221 | Q02156 | |
| PGGDKISVTNQNRKE | 601 | Q5U5R9 | |
| VQLVQSGAEVKKPGA | 21 | A0A0C4DH33 | |
| VQLVQSGAEVKKPGA | 21 | P0DP01 | |
| EGPKKAVNDVNGLKQ | 41 | Q99848 | |
| PQGKNTVELLVEDKG | 396 | O75369 | |
| VQAQGPGLKEAFTNK | 1331 | O75369 | |
| LEGRVAPKTVQEGKQ | 1276 | Q9Y6V0 | |
| VGTGPKNDNKLTRQE | 271 | Q86W56 | |
| SKVGGNLPLILQKFQ | 181 | Q6UY01 | |
| VNQDGQPLIEGKLKE | 711 | Q14D04 | |
| KKQQQGFPEILTAGD | 6 | Q9ULH7 | |
| KGLPKTQNGEIVQFK | 466 | Q9P265 | |
| IPQEKKNSGLNCGTQ | 21 | Q12986 | |
| NGKLVTEPLVLKSGN | 571 | O43896 | |
| NDGKKNNPAIVIIGN | 156 | P49257 | |
| VEGIQQFQLRGKPKA | 401 | Q8TB73 | |
| NTKGQLVVNPEALKI | 16 | P32456 | |
| ENALKLISGKNPQIQ | 201 | Q8N8V2 | |
| PIEVNNGLGKSQAKN | 441 | P48167 | |
| KQLVSLGPEKSVEGQ | 1146 | P00451 | |
| NNKVVSPGFRKNGIV | 5006 | P98088 | |
| VQLVQSGAEVKKPGA | 21 | A0A0G2JMI3 | |
| VQLVQSGAEVKKPGA | 21 | P23083 | |
| GKKAQLNIGNVLPVG | 91 | P62917 | |
| GVGKPAKQLQDLRNA | 696 | Q8IYI6 | |
| QSKLIQKGNDRPNGE | 866 | O00222 | |
| VQLVQSGAEVKKPGA | 21 | A0A0C4DH29 | |
| EKFVQGLDIGPTKTQ | 196 | P17301 | |
| KDGLNTKPSQVLQGV | 426 | P53708 | |
| VQLVQSGAEVKKPGA | 21 | A0A0C4DH31 | |
| KKGVNPLLEEAVGQQ | 856 | Q9NY74 | |
| QNPAGTALGKIKLNV | 4061 | Q96RW7 | |
| VQLVQSGAEVKKPGE | 21 | A0A0C4DH38 | |
| IAIFGPGDDAVKQQK | 736 | P21439 | |
| LEKQVLGLQKGQQTG | 651 | Q86Y26 | |
| IPNIQAKGLGKNSEE | 771 | Q9Y5F2 | |
| TIKEGNKPVLFQGNT | 371 | O14786 | |
| VQLVQSGSELKKPGA | 21 | A0A0J9YVY3 | |
| KPNGGNILVTEENKE | 721 | Q96J02 | |
| ESLQLEGGKLVKAPQ | 121 | B2RXH4 | |
| GANGVILDNQPIVKK | 2416 | Q3L8U1 | |
| AEIQGKPTLQLKLQG | 76 | Q9NZH7 | |
| PEVGLTENGKVILKN | 191 | P49915 | |
| FSSQKGVKGVPLNLQ | 361 | Q8TE85 | |
| QLGETGKVTDINLPQ | 431 | Q8NA47 | |
| PVDLKVGTNIQNFKL | 576 | Q6ZTQ4 | |
| ILEQKRQNPGSVGQK | 966 | Q9P2H0 | |
| QLPVTFGNKQKVLGK | 256 | Q9H0C5 | |
| GIKGLQLKVNLQPND | 3856 | Q8N3K9 | |
| EKFVAVLGGNIKQNP | 451 | A8MPP1 | |
| NVNVLTKTKGPGDKQ | 211 | Q5T1N1 | |
| KPEVKKTATQNGLNG | 496 | O60266 | |
| GSLENVPNVGVNKNI | 236 | P53004 | |
| AEGQQAQVEKVPKLL | 626 | Q96JA4 | |
| SQKIKPQVTLQGGAA | 196 | Q56NI9 | |
| KVGDTVNLLIPFQGK | 66 | A2RUH7 | |
| LEIKQLGNRSQPGIK | 1856 | Q8TEP8 | |
| EALPGDNVGFKVKNV | 301 | Q5VTE0 | |
| KLLEQGNISIPKSNG | 476 | A6NNW6 | |
| GSGTQEPEKKIVQEL | 96 | Q7Z6J4 | |
| NFVGKILGPQGNTIK | 171 | Q07666 | |
| GNICGQKNTKLEAIP | 66 | Q8WWI5 | |
| PGFKNNKGVAEVLQD | 141 | Q8IWA5 | |
| QGVKLFAVGIKNADP | 166 | Q02388 | |
| NGNGKEKIRIESPVL | 126 | Q17RY0 | |
| NKAIGTPSVGVLLKQ | 956 | Q5TBA9 | |
| KANETENDIKVLGGP | 1541 | Q8NDH2 | |
| QKGLPKAQTGEVAAF | 461 | Q14689 | |
| KQEPGTNSEILLGLK | 106 | P59796 | |
| VEPLDFGGTQKQKQL | 466 | P07686 | |
| EEFVNGLDKQVKNGP | 251 | Q5VT52 | |
| GLDKQVKNGPSLTEA | 256 | Q5VT52 | |
| QVVKDGLNQKPEKGE | 471 | P46059 | |
| QGGKEESPFVNINKK | 626 | Q9H329 | |
| PENILLKQQGRSGIK | 351 | Q92630 | |
| SSNGPGEILNKEEVK | 406 | Q8N108 | |
| GVAPGKAVKNVQINS | 1596 | Q16363 | |
| PGKIQIGNQVFSGKT | 1496 | Q2WGJ9 | |
| NVKNGSDLGISQKPI | 796 | O95197 | |
| NGVQLPALGENKKVI | 181 | P54136 | |
| TCQGSGKIPQELEKQ | 61 | Q96A25 | |
| EQILNGGESPKQKGQ | 221 | Q13033 | |
| FNKEKIIQGQGVDEP | 16 | Q9NQ88 | |
| GVLGPKNVSQKDAEF | 21 | Q8NBJ9 | |
| RVSVNVLNKQKGAPL | 66 | Q8NBJ9 | |
| QLQDELPGTSQAKGK | 471 | B4DYI2 | |
| GLEQNNTVKGKVPLQ | 121 | O43897 | |
| VQAEKGLQRDLPGKQ | 571 | Q6ZMZ3 | |
| NLTGLPGTEKLNEKE | 366 | O75478 | |
| KPTSLKTIIGQQGDQ | 591 | P35251 | |
| LLGKTGVIKEEPQQN | 541 | P21675 | |
| KPFQGVKNNDVIGRI | 621 | Q05397 | |
| KAENGKLVINGNPIT | 61 | P04406 | |
| CGDGNVVKQEQLSPK | 716 | Q9Y6Q9 | |
| KQAKLTEDGLPLGVN | 166 | Q02127 | |
| VFQELGKLTGPNNQK | 201 | P13521 | |
| PGKTILGIQCELQKQ | 2471 | Q9UKZ4 | |
| QVDVDTVKGGLKLNP | 426 | Q13228 | |
| GFSAGQVQLIDPIKK | 121 | Q8TBZ3 | |
| VTIDNIKLPNSEGGK | 156 | Q8N5I9 | |
| NEKIKNLIPEGNIGS | 156 | P29508 | |
| QQLKLEGPGEQETKL | 236 | Q99808 | |
| QPQQGSGLCEKDVKK | 556 | Q8WYL5 | |
| KVQAGQVDVKLLEGP | 2211 | Q8IVF2 | |
| KGKNPTGLLALQQIA | 81 | P35611 | |
| SPVVGRSQGQQQEKK | 181 | P52594 | |
| NEETGDNVGPLIIKK | 91 | Q9NZ45 | |
| NGQIFKVNTLLEPKV | 1646 | Q17RW2 | |
| SLGKLQKQPAVGINS | 1261 | O75094 | |
| VDQRPKGQGNKVSVQ | 6 | Q7Z739 | |
| KLIKIQEGNLRPGTN | 126 | Q96NL3 | |
| QGILPEQGIQDSFKK | 51 | Q8TB69 | |
| LQGGKEQKQPLQVAK | 21 | Q9UMS6 | |
| NGKIIEKIQGANAPL | 91 | Q8N427 | |
| QGVGQIQLKGDILPN | 761 | Q76I76 | |
| NLGKVDIFVKDVQPG | 156 | Q8NI35 | |
| IPNAGDATKAIKQQI | 676 | Q9NUY8 | |
| VQFKNGDGQPKAVRV | 2226 | P22105 | |
| ANPTQILGKLKELNG | 546 | Q9Y263 | |
| NSIKKGELPSELQGI | 91 | P68543 | |
| LREGSQEKTGQQQKP | 66 | Q5T1R4 | |
| VTNKIPGANKEINLL | 1296 | Q9HCK1 | |
| LKSENKGNDPNIVIV | 66 | Q5JSZ5 | |
| NEKIKNLFPDGTIGN | 156 | P48594 | |
| QPGGGKVQIINKKLD | 586 | P10636 | |
| PIGNTTGKENKVLLA | 186 | Q9UBV4 | |
| GKTKNGVPEAVQLIN | 1551 | P08922 | |
| VDGGNPKIITNLSKQ | 1256 | O94813 | |
| KDNVPSNQIIGGEQK | 1171 | Q6AHZ1 | |
| GSKPGKNVQLQENEI | 21 | P36873 | |
| PSIKENIGSVFGQKQ | 221 | P54278 | |
| QLVAGKEPANVGVTK | 101 | Q9BW30 | |
| GCPQDKSGQLKVELQ | 36 | Q6ZNB5 | |
| QLSKPGVISQLEKGE | 116 | Q9UJL9 | |
| AGAIGIVKQNVNKEA | 76 | Q86YA3 | |
| PEGKIGNQVEKSINN | 156 | P17035 | |
| IEPKFQQTGKELQEG | 411 | Q01118 | |
| AKIQNKNCPGIGKVD | 71 | Q8N883 | |
| KGEISPGKINSVEQN | 156 | Q96T83 | |
| PQGQGAQIKKSVSDV | 316 | Q5SRN2 | |
| LKEFVAKEGQGNLPV | 311 | Q13564 | |
| KQFTKQNGETPGIIA | 106 | P15822 | |
| TSPKLVQNNLGGKVE | 781 | Q5VZL5 | |
| SFPLKGITEQQKEGL | 191 | P13010 | |
| NISAIIQGIGKDKEP | 321 | Q15911 | |
| QIKGLFQKEQPAGER | 551 | Q9NS93 | |
| NQVTKARGAIPSGKQ | 1041 | Q96PN7 | |
| LEKIQGAQKEPGNKS | 1991 | Q14789 | |
| AGLEQKLQGTPSNKE | 4496 | O14686 | |
| KNTIAIGVDPQEGKV | 1081 | O75096 | |
| TVNPKGELIQERTKG | 831 | Q92539 | |
| LGGKATIPEVKNSEN | 81 | Q5T7N2 | |
| QGVPKEKLTGTIQND | 206 | P22033 | |
| IEALKSGIQGKIPAN | 671 | Q9NZM1 | |
| LNGKGLNVKQAFNPE | 466 | Q9UBF9 |